MedWaves AveCure® Microwave Ablation System Used to Successfully Treat Recurrent Brain Tumor Following Five Micro-Surgeries and Full Regiment of Radiation Therapy

MedWaves AveCure® Microwave Ablation System Used to Successfully Treat Recurrent Brain Tumor Following Five Micro-Surgeries and Full Regiment of Radiation Therapy

Press Release (ePRNews.com) - SAN DIEGO - May 02, 2020 - Doctor Santana, a neurosurgeon and his fellows at a major hospital in Guadalajara, Mexico has successfully treated a patient with recurrent malignant meningioma with microwave ablation. The patient had previously failed five (5) surgeries and full dosage of radiation.

Following the failure of the 5th surgical attempt and 30 days in the hospital, microwave ablation (MWA) system developed MedWaves, Inc., San Diego, CA was used to treat the patient. The patient was discharged from the hospital on the 8th day following the MWA with Karnofsky score of 90, which means; he can carry out normal activity with minor symptoms. The magnetic resonance imaging prior to discharge showed significant tumor volume reduction resulting from the MWA. The patient continues to improve and currently being considered for additional intervention with MWA to remove nasal obstruction and pain in the eyes.

MedWaves, Inc is a privately held company with headquarter and manufacturing in San Diego, CA. www.medwaves.com, tedormsby@avecure.com,

Mobile: 760-807-1000

Source : MedWaves, Inc.
SHARE :  
Business Info :
MedWaves, Inc.

You may also like this  

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or Signup using Email

Already have an account ? Login

Reset Password

Already have an account ? Login

DISCLAIMER

If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/ services/ business mentioned and hereby disclaims any content contained in this press release.